nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Auditory adaptation is differentially impaired in familial and sporadic Alzheimer’s disease
|
Tarkka, I.M |
|
2002 |
56 |
1 |
p. 45-49 5 p. |
artikel |
2 |
Estrogens and environmental estrogens
|
Tapiero, H |
|
2002 |
56 |
1 |
p. 36-44 9 p. |
artikel |
3 |
Interplays between genetic and environmental mechanisms trigger tumorigenic VEGF signalling in human HCC cell lines: pilot study
|
Fang, Y |
|
2002 |
56 |
1 |
p. 50-55 6 p. |
artikel |
4 |
Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case – a modern Pandora’s box
|
Bliznakov, E.G |
|
2002 |
56 |
1 |
p. 56-59 4 p. |
artikel |
5 |
Management of erythema nodosum leprosum by thalidomide: thalidomide analogues inhibit M. leprae -induced TNFα production in vitro
|
Sampaio, E.P. |
|
2002 |
56 |
1 |
p. 13-19 7 p. |
artikel |
6 |
Notes
|
|
|
2002 |
56 |
1 |
p. 60-61 2 p. |
artikel |
7 |
Thalidomide, a drug which may protect the organism against some aggressive effects of the immunologic system
|
Mathé, G |
|
2002 |
56 |
1 |
p. 1-3 3 p. |
artikel |
8 |
Thalidomide in Behçet’s disease
|
Shek, L.P.C |
|
2002 |
56 |
1 |
p. 31-35 5 p. |
artikel |
9 |
Thalidomide in cancer
|
Singhal, S |
|
2002 |
56 |
1 |
p. 4-12 9 p. |
artikel |
10 |
Thalidomide in myelodysplastic syndromes
|
Zorat, F |
|
2002 |
56 |
1 |
p. 20-30 11 p. |
artikel |